What is Longevity Medicine 201?

The Longevity Medicine 201 is a translational course allowing physicians to gain the fundamentals in the field, including theories of aging, biomarkers of aging, molecular mechanisms, and geroprotector regimens. The course serves to provide an overview of clinical applications of recent advances in aging research, skills to evaluate the validity of biomarkers of aging and other biological age testing systems, and knowledge of the available longevity therapies to tackle diseases related to senescence-related processes in the organisms.

Course Highlights

Longevity Medicine 201 course
provides you with:

  • AI-narrated core lectures from experts in the field
  • Supplementary materials: slides and notes
  • References to reading materials and online resources
  • Quizzes to track your progress
  • Certificate of completion
Course Highlights illustration
What you'll learn illustration

What you'll learn

  • Fundamentals of aging research: terminology, key notions, theories, and hallmarks of aging
  • Toolkit for tracking and measuring aging: from simple biomarkers to deep aging clocks
  • Molecular regulatory pathways linked with longevity
  • Geroprotective interventions and clinically available geroprotectors
  • AI technology in Longevity Medicine

Course Curriculum

Take this course for FREE

Important Notice: To proceed with the Longevity Medicine 201 Course and obtain certification, it is MANDATORY to provide all required details in the survey at the beginning of the course.


Course Completion Certificate

After taking all lectures and passing the final quiz, students are able to unlock the course certificate. The certificate will appear on the screen and will be available for download.

Course Authors


Alex Zhavoronkov, PhD

Alex Zhavoronkov, PhD

LinkedIn

Course Founder & Author

Alex Zhavoronkov, PhD, is the founder and Chief Longevity Officer of Deep Longevity, Inc, a global company developing a broad range of artificial intelligence-based biomarkers of aging and longevity. He is also the founder and CEO of Insilico Medicine (insilico.com), a leader in next-generation artificial intelligence technologies for drug discovery, and biomarker development.

Evelyne Bischof, MD, PhD

Evelyne Bischof, MD, PhD

LinkedIn

Course Founder & Author

Dr. Bischof is a specialist in internal medicine, with research focus on Artificial Intelligence (AI) and digital health, especially in the fields of oncology, preventative and precision medicine, biogerontology, and geronto-oncology. She is also a longevity physician at Human Longevity and board member of various internal medicine societies.

Alexey Moskalev, MD

Alexey Moskalev, MD

LinkedIn

Course Co-Author

Dr. Moskalev is a biologist specializing in the genetics of aging and geroprotectors that extend healthy lifespan. He heads the Laboratory of Geroprotective and Radioprotective Technologies at the Institute of Biology of the Komi Scientific Centre and leads the Department of Ecology at Syktyvkar State University.